Wuhan, China

Bo Hu

This inventor holds 2 USPTO granted patents. Top assignees: Futu Biotech Co., Ltd., Hubei Zhuzhao Biotechnology Co., Ltd.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bo Hu. Retrieved from https://idiyas.com/inventor/bo-hu-qrfeftlq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bo Hu: Innovator in Nano Small Peptide Research

Introduction

Bo Hu is a prominent inventor based in Wuhan, China, known for his significant contributions to the field of biotechnology. He holds two patents that focus on the development of nano small peptides for medical applications, particularly in treating fundus vascular diseases. His innovative work has the potential to advance therapeutic strategies in this critical area of health.

Latest Patents

Bo Hu's latest patents include the development of a nano small peptide designed for the preparation of drugs aimed at treating and preventing fundus vascular diseases. The first patent describes a nano small peptide with the molecular formula X-FFVLK-KQKRPRH, where X can be dodecanoyl, tetradecanoyl, hexadecanoyl, or octadecanoyl. This peptide selectively targets receptors to encapsulate the sSemaD protein, effectively reducing its concentration and preventing it from binding to receptors. This innovation addresses the limitations of existing antibody drugs by providing additional inhibitory targets. The second patent features a similar nano small peptide, FG, with the molecular formula X-FFVLKKNKAAKG, which also targets sSema4D protein, enhancing the therapeutic potential against pro-angiogenesis molecules.

Career Highlights

Throughout his career, Bo Hu has worked with notable companies in the biotechnology sector, including Futu Biotech Co., Ltd. and Hubei Zhuzhao Biotechnology Co., Ltd. His experience in these organizations has contributed to his expertise in peptide synthesis and drug development.

Collaborations

Bo Hu has collaborated with several professionals in his field, including Yanan Li and Hao Wang. These partnerships have facilitated the advancement of his research and the successful development of his patented technologies.

Conclusion

Bo Hu's innovative work in the field of nano small peptides represents a significant advancement in the treatment of fundus vascular diseases. His contributions are poised to make a lasting impact on medical science and therapeutic practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…